$1.22
3.17%
NYSE, Nov 14, 10:00 pm CET
ISIN
US75062E1064
Symbol
RFL

Rafael Holdings Inc - Ordinary Shares - Class B Stock price

$1.22
-0.08 6.15% 1M
-0.17 12.23% 6M
-0.43 26.06% YTD
-0.64 34.41% 1Y
-0.62 33.70% 3Y
-19.99 94.25% 5Y
-3.68 75.10% 10Y
-3.68 75.10% 20Y
NYSE, Closing price Fri, Nov 14 2025
-0.04 3.17%

Key metrics

Basic
Market capitalization
$63.2m
Enterprise Value
$10.9m
Net debt
positive
Cash
$53.0m
Shares outstanding
-
Valuation (TTM | estimate)
P/E
- | -
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
0.7
Financial Health
Equity Ratio
82.5%
Return on Equity
-
ROCE
-
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
- | -
EBITDA
- | -
EBIT
- | -
Net Income
- | -
Free Cash Flow
$-19.0m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
- | -
EBIT
- | -
Net Income
- | -
Free Cash Flow
-138.4%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
-
FCF per Share
-
Short interest
0.1%
Employees
30
Rev per Employee
-
Show more

Is Rafael Holdings Inc - Ordinary Shares - Class B a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

Rafael Holdings Inc - Ordinary Shares - Class B Stock Analysis

Unlock Scores for Free

Financial data from Rafael Holdings Inc - Ordinary Shares - Class B

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Apr '25
+/-
%
0.73 0.73
35% 35%
100%
- Direct Costs 0.19 0.19
111% 111%
26%
0.55 0.55
120% 120%
75%
- Selling and Administrative Expenses 11 11
34% 34%
1,453%
- Research and Development Expense 6.82 6.82
93% 93%
934%
-20 -20
80% 80%
-2,730%
- Depreciation and Amortization 0.31 0.31
72% 72%
42%
EBIT (Operating Income) EBIT -20 -20
80% 80%
-2,773%
Net Profit -23 -23
19% 19%
-3,137%

In millions USD.

Don't miss a Thing! We will send you all news about Rafael Holdings Inc - Ordinary Shares - Class B directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Rafael Holdings Inc - Ordinary Shares - Class B Stock News

Neutral
GlobeNewsWire
19 days ago
Cyclo Therapeutics' TransportNPC™ Phase 3 clinical trial for  Trappsol ® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is continuing at the recommendation of the Data Monitoring Committee (DMC) following their review of prespecified safety and efficacy date at 48 weeks
Neutral
GlobeNewsWire
20 days ago
NEWARK, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) sadly announced today the passing of its Lead Independent Director, Stephen Greenberg, and the appointment of Alan Grayson to its Board of Directors. Mr. Grayson will serve on the Compensation, Corporate Governance and Nominating Committees. Separately, the Company also announced that Markus...
Neutral
GlobeNewsWire
2 months ago
First data on treatment of NPC1 with Trappsol ® Cyclo™ (hydroxypropyl-beta-cyclodextrin) in this age group over a period of 48 weeks At 48 weeks of the sub-study, 7 of 9 patients 1 showed stabilization or improvement in CGI-S score Data presented at the15 th International Congress of Inborn Errors of Metabolism (ICIEM) NEWARK, N.J., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE...
More Rafael Holdings Inc - Ordinary Shares - Class B News

Company Profile

Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. It operates through the Real Estate and Pharmaceuticals segments. The Real Estate segment refers to the real estate holdings. The Pharmaceuticals segment is comprised of debt interests and warrants in Rafael Pharmaceuticals and a majority equity interest in LipoMedix Pharmaceuticals. The company is headquartered in Newark, NJ.

Head office United States
CEO William Conkling
Employees 30
Founded 2017
Website rafaelholdings.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today